{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T10:58:28Z","timestamp":1791457108702,"version":"4.3.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":17,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100017481","name":"Ulusal Metroloji Enstit\u00fcs\u00fc, T\u00fcrkiye Bilimsel ve Teknolojik Ara\u015ftirma Kurumu","doi-asserted-by":"publisher","award":["121S307"],"award-info":[{"award-number":["121S307"]}],"id":[{"id":"10.13039\/501100017481","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>No serum biomarker has yet been validated for clinical use in neonatal hypoxic-ischemic encephalopathy (HIE). Orexin-A is a hypothalamic neuropeptide that has demonstrated neuroprotective effects in experimental models of cerebral hypoxia\u2013ischemia. We aimed to describe the early temporal profile of serum orexin-A in neonates with HIE, to compare its longitudinal change according to therapeutic hypothermia (TH) exposure, and to examine its relationship with clinical severity, electrophysiological findings and brain imaging.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This prospective longitudinal observational study enrolled 41 neonates born at \u2265\u200936 weeks\u2019 gestation in whom HIE was diagnosed within the first 6 postnatal hours. Serum orexin-A was measured at 6\u201312\u00a0h and at 72\u201396\u00a0h after birth. Longitudinal changes were compared between neonates who received TH and those managed without TH, and were examined against clinical severity, amplitude-integrated and video electroencephalography (EEG), brain magnetic resonance imaging (MRI) and routine metabolic indices.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Twenty-two neonates received TH and 19 were managed without TH. Orexin-A concentrations did not differ between groups at either time point (6\u201312\u00a0h,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.078; 72\u201396\u00a0h,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.082). The within-subject change from 6\u201312\u00a0h to 72\u201396\u00a0h did differ, with relative preservation under TH and a decline without it (median\u2009+\u200931.2 vs. \u221254.5 pg\/mL;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.002), and more neonates in the TH group had a higher value at the second measurement (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.012). Orexin-A fell significantly over time in the normothermia group (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.005). The change also differed by amplitude-integrated EEG background (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.010), although abnormal tracings were almost confined to the TH group. Neither concentration nor change was related to video EEG findings, MRI abnormality or metabolic indices. Higher 72\u201396\u00a0h concentrations tracked clinical severity only in outlier-sensitive analyses.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Serum orexin-A followed different early trajectories in neonates managed with and without hypothermia, and the clinical signal lay in the direction of change rather than in any single concentration. Because treatment allocation was inseparable from disease severity, these trajectories cannot be attributed to cooling itself. Orexin-A behaves as a marker of functional state rather than of tissue injury, and serial sampling in larger, severity-matched cohorts with neurodevelopmental follow-up is required before any clinical role can be defined.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12887-026-07727-0","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T10:54:37Z","timestamp":1789988077000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Temporal profile of serum orexin-A in neonatal hypoxic-ischemic encephalopathy: a prospective longitudinal study"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3223-5408","authenticated-orcid":false,"given":"P\u0131nar","family":"Gen\u00e7p\u0131nar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5887-6468","authenticated-orcid":false,"given":"Gunce","family":"Basarir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2404-170X","authenticated-orcid":false,"given":"Atilla","family":"Ersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0405-085X","authenticated-orcid":false,"given":"Defne","family":"Eng\u00fcr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5902-3501","authenticated-orcid":false,"given":"Nihal","family":"Olga\u00e7 D\u00fcndar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1440-3754","authenticated-orcid":false,"given":"H\u00fcseyin","family":"\u00dcst\u00fcn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0043-2263","authenticated-orcid":false,"given":"Melike","family":"Kefeli Demirel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6714-2367","authenticated-orcid":false,"given":"Fatma Ceren","family":"Sar\u0131o\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1483-997X","authenticated-orcid":false,"given":"Banu","family":"\u0130\u015fbilen Ba\u015fok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,21]]},"reference":[{"key":"7727_CR1","doi-asserted-by":"publisher","first-page":"F346","DOI":"10.1136\/archdischild-2015-309639","volume":"102","author":"K Martinello","year":"2017","unstructured":"Martinello K, Hart AR, Yap S, Mitra S, Robertson NJ. Management and investigation of neonatal encephalopathy:2017 update. Arch Dis Child Fetal Neonatal Ed. 2017;102:F346\u201358. https:\/\/doi.org\/10.1136\/archdischild-2015-309639.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"7727_CR2","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1038\/s41390-023-02775-z","volume":"94","author":"EJ Molloy","year":"2023","unstructured":"Molloy EJ, Branagan A, Hurley T, Quirke F, Devane D, Taneri PE, El-Dib M, Bloomfield FH, Maeso B, Pilon B, Bonifacio SL, Wusthoff CJ, Chalak L, Bearer C, Murray DM, Badawi N, Campbell S, Mulkey S, Gressens P, Ferriero DM, de Vries LS, Walker K, Kay S, Boylan G, Gale C, Robertson NJ, D\u2019Alton M, Gunn A, Nelson KB. Steering Group for DEFiNE (Definition of Neonatal Encephalopathy). Neonatal encephalopathy and hypoxic\u2013ischemic encephalopathy: moving from controversy to consensus definitions and subclassification. Pediatr Res. 2023;94:1860\u201363. https:\/\/doi.org\/10.1038\/s41390-023-02775-z.","journal-title":"Pediatr Res"},{"key":"7727_CR3","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.pediatrneurol.2023.08.037","volume":"149","author":"MC Cornet","year":"2023","unstructured":"Cornet MC, Kuzniewicz M, Scheffler A, Forquer H, Hamilton E, Newman TB, Wu YW. Perinatal hypoxic-ischemic encephalopathy: incidence over time within a modern US birth cohort. Pediatr Neurol. 2023;149:145\u201350. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2023.08.037.","journal-title":"Pediatr Neurol"},{"key":"7727_CR4","doi-asserted-by":"publisher","first-page":"23100","DOI":"10.1038\/s41598-023-50187-0","volume":"13","author":"J Park","year":"2023","unstructured":"Park J, Park SH, Kim C, Yoon SJ, Lim JH, Han JH, Shin JE, Eun HS, Park MS, Lee SM. Growth and developmental outcomes of infants with hypoxic ischemic encephalopathy. Sci Rep. 2023;13:23100. https:\/\/doi.org\/10.1038\/s41598-023-50187-0.","journal-title":"Sci Rep"},{"key":"7727_CR5","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s13760-020-01308-3","volume":"120","author":"P Greco","year":"2020","unstructured":"Greco P, Nencini G, Piva I, Scioscia M, Volta CA, Spadaro S, Neri M, Bonaccorsi G, Greco F, Cocco I, Sorrentino F, D\u2019Antonio F, Nappi L. Pathophysiology of hypoxic-ischemic encephalopathy: a review of the past and a view on the future. Acta Neurol Belg. 2020;120:277\u201388. https:\/\/doi.org\/10.1007\/s13760-020-01308-3.","journal-title":"Acta Neurol Belg"},{"key":"7727_CR6","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1001\/jamapediatrics.2014.3269","volume":"169","author":"M Douglas-Escobar","year":"2015","unstructured":"Douglas-Escobar M, Weiss MD. Hypoxic-ischemic encephalopathy: a review for the clinician. JAMA Pediatr. 2015;169:397\u2013403. https:\/\/doi.org\/10.1001\/jamapediatrics.2014.3269.","journal-title":"JAMA Pediatr"},{"key":"7727_CR7","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1203\/00006450-199412000-00003","volume":"36","author":"A Lorek","year":"1994","unstructured":"Lorek A, Takei Y, Cady EB, Wyatt JS, Penrice J, Edwards AD, Peebles D, Wylezinska M, Owen-Reece H, Kirkbride V, Cooper CE, Aldridge RF, Roth SC, Brown G, Delpy DT. Reynolds EOR. Delayed (secondary) cerebral energy failure after acute hypoxia-ischemia in the newborn piglet: continuous 48-hour studies by phosphorus magnetic resonance spectroscopy. Pediatr Res. 1994;36:699\u2013706. https:\/\/doi.org\/10.1203\/00006450-199412000-00003.","journal-title":"Pediatr Res"},{"key":"7727_CR8","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/ana.22670","volume":"71","author":"L Bennet","year":"2012","unstructured":"Bennet L, Tan S, Van den Heuij L, Derrick M, Groenendaal F, van Bel F, Juul S, Back SA, Northington F, Robertson NJ, Mallard C, Gunn AJ. Cell therapy for neonatal hypoxia-ischemia and cerebral palsy. Ann Neurol. 2012;71:589\u2013600. https:\/\/doi.org\/10.1002\/ana.22670.","journal-title":"Ann Neurol"},{"key":"7727_CR9","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1097\/01.AOG.0000445580.65983.d2","volume":"123","author":"American College of Obstetricians and Gynecologists\u2019 Task Force on Neonatal Encephalopathy","year":"2014","unstructured":"American College of Obstetricians and Gynecologists\u2019 Task Force on Neonatal Encephalopathy. Executive Summary: Neonatal Encephalopathy and Neurologic Outcome, Second Edition. Obstet Gynecol. 2014;123:896\u2013901. https:\/\/doi.org\/10.1097\/01.AOG.0000445580.65983.d2.","journal-title":"Obstet Gynecol"},{"key":"7727_CR10","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1001\/archneur.1976.00500100030012","volume":"33","author":"HB Sarnat","year":"1976","unstructured":"Sarnat HB, Sarnat MS. Neonatal encephalopathy following fetal distress: a clinical and electroencephalographic study. Arch Neurol. 1976;33:696\u2013705. https:\/\/doi.org\/10.1001\/archneur.1976.00500100030012.","journal-title":"Arch Neurol"},{"key":"7727_CR11","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1111\/j.1651-2227.1997.tb08581.x","volume":"86","author":"CM Thompson","year":"1997","unstructured":"Thompson CM, Puterman AS, Linley LL, Hann FM, van der Elst CW, Molteno CD, Malan AF. The value of a scoring system for hypoxic ischaemic encephalopathy in predicting neurodevelopmental outcome. Acta Paediatr. 1997;86:757\u201361. https:\/\/doi.org\/10.1111\/j.1651-2227.1997.tb08581.x.","journal-title":"Acta Paediatr"},{"key":"7727_CR12","unstructured":"British Association of Perinatal Medicine. Therapeutic hypothermia for neonatal encephalopathy: a framework for practice. British Association of Perinatal Medicine; 2020. https:\/\/www.bapm.org\/resources\/237-therapeutic-hypothermia-for-neonatal-encephalopathy. Accessed 6 Sep 2026."},{"key":"7727_CR13","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s12519-023-00698-7","volume":"19","author":"I Caramelo","year":"2023","unstructured":"Caramelo I, Coelho M, Rosado M, Cardoso CMP, Dinis A, Duarte CB, Gr\u00e3os M, Manadas B. Biomarkers of hypoxic-ischemic encephalopathy: a systematic review. World J Pediatr. 2023;19:505\u201348. https:\/\/doi.org\/10.1007\/s12519-023-00698-7.","journal-title":"World J Pediatr"},{"key":"7727_CR14","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s00109-002-0322-x","volume":"80","author":"CT Beuckmann","year":"2002","unstructured":"Beuckmann CT, Yanagisawa M. Orexins: from neuropeptides to energy homeostasis and sleep\/wake regulation. J Mol Med (Berl). 2002;80:329\u201342. https:\/\/doi.org\/10.1007\/s00109-002-0322-x.","journal-title":"J Mol Med (Berl)"},{"key":"7727_CR15","doi-asserted-by":"publisher","first-page":"5282","DOI":"10.1523\/JNEUROSCI.22-13-05282.2002","volume":"22","author":"LI Kiyashchenko","year":"2002","unstructured":"Kiyashchenko LI, Mileykovskiy BY, Maidment N, Lam HA, Wu MF, John J, Peever J, Siegel JM. Release of hypocretin (orexin) during waking and sleep states. J Neurosci. 2002;22:5282\u20136. https:\/\/doi.org\/10.1523\/JNEUROSCI.22-13-05282.2002.","journal-title":"J Neurosci"},{"key":"7727_CR16","doi-asserted-by":"publisher","first-page":"109839","DOI":"10.1016\/j.cellsig.2020.109839","volume":"79","author":"D Xu","year":"2021","unstructured":"Xu D, Kong T, Zhang S, Cheng B, Chen J, Wang C. Orexin-A protects against cerebral ischemia-reperfusion injury by inhibiting excessive autophagy through OX1R-mediated MAPK\/ERK\/mTOR pathway. Cell Signal. 2021;79:109839. https:\/\/doi.org\/10.1016\/j.cellsig.2020.109839.","journal-title":"Cell Signal"},{"key":"7727_CR17","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1097\/ALN.0b013e318206ff6f","volume":"114","author":"LB Yuan","year":"2011","unstructured":"Yuan LB, Dong HL, Zhang HP, Zhao RN, Gong G, Chen XM, Zhang LN, Xiong L. Neuroprotective effect of orexin-A is mediated by an increase of hypoxia-inducible factor-1 activity in rat. Anesthesiology. 2011;114:340\u201354. https:\/\/doi.org\/10.1097\/ALN.0b013e318206ff6f.","journal-title":"Anesthesiology"},{"issue":"Suppl 1","key":"7727_CR18","doi-asserted-by":"publisher","first-page":"32","DOI":"10.5152\/TurkPediatriArs.2018.01805","volume":"53","author":"M Akisu","year":"2018","unstructured":"Akisu M, Kumral A, Canpolat FE. Turkish Neonatal Society Guideline on neonatal encephalopathy. Turk Arch Pediatr. 2018;53(Suppl 1):32\u201344. https:\/\/doi.org\/10.5152\/TurkPediatriArs.2018.01805.","journal-title":"Turk Arch Pediatr"},{"issue":"9","key":"7727_CR19","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/S2352-4642(26)00101-X","volume":"10","author":"A Branagan","year":"2026","unstructured":"Branagan A, Hurley T, Byrne D, Quirke F, Devane D, Taneri PE, Badawi N, Bearer CF, Bloomfield FH, Bonifacio SL, Boylan G, Campbell SK, Chalak L, D\u2019Alton M, de Vries LS, El-Dib M, Ferriero DM, Gale C, Gressens P, Gronlund T, Gunn AJ, Kay S, Murray DM, Nelson KB, Pilon B, Robertson NJ, Walker K, Wusthoff CJ, Molloy EJ. Steering Group for DEFiNE (Definition of Neonatal Encephalopathy). Defining neonatal encephalopathy: an international real-time Delphi consensus process. Lancet Child Adolesc Health. 2026;10(9):679\u201386. https:\/\/doi.org\/10.1016\/S2352-4642(26)00101-X.","journal-title":"Lancet Child Adolesc Health"},{"key":"7727_CR20","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1038\/s41390-022-01994-0","volume":"93","author":"Z Yang","year":"2023","unstructured":"Yang Z, Xu H, Sura L, Arja RD, Patterson RL, Rossignol C, Albayram M, Rajderkar D, Ghosh S, Wang K, Weiss MD. Combined GFAP, NFL, Tau, and UCH-L1 panel increases prediction of outcomes in neonatal encephalopathy. Pediatr Res. 2023;93:1199\u2013207. https:\/\/doi.org\/10.1038\/s41390-022-01994-0","journal-title":"Pediatr Res"},{"key":"7727_CR21","doi-asserted-by":"publisher","first-page":"4163","DOI":"10.1038\/s41467-022-31591-y","volume":"13","author":"R De Luca","year":"2022","unstructured":"De Luca R, Nardone S, Grace KP, Venner A, Cristofolini M, Bandaru SS, Sohn LT, Kong D, Mochizuki T, Viberti B, Zhu L, Zito A, Scammell TE, Saper CB, Lowell BB, Fuller PM, Arrigoni E. Orexin neurons inhibit sleep to promote arousal. Nat Commun. 2022;13:4163. https:\/\/doi.org\/10.1038\/s41467-022-31591-y.","journal-title":"Nat Commun"},{"key":"7727_CR22","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.5665\/sleep.2232","volume":"35","author":"GM Mang","year":"2012","unstructured":"Mang GM, D\u00fcrst T, B\u00fcrki H, Imobersteg S, Abramowski D, Schuepbach E, Hoyer D, Fendt M, Gee CE. The dual orexin receptor antagonist almorexant induces sleep and decreases orexin-induced locomotion by blocking orexin 2 receptors. Sleep. 2012;35:1625\u201335. https:\/\/doi.org\/10.5665\/sleep.2232.","journal-title":"Sleep"},{"key":"7727_CR23","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1756-6606-1-19","volume":"1","author":"OJ Marston","year":"2008","unstructured":"Marston OJ, Williams RH, Canal MM, Samuels RE, Upton N, Piggins HD. Circadian and dark-pulse activation of orexin\/hypocretin neurons. Mol Brain. 2008;1:19. https:\/\/doi.org\/10.1186\/1756-6606-1-19.","journal-title":"Mol Brain"},{"key":"7727_CR24","doi-asserted-by":"publisher","first-page":"102019","DOI":"10.1016\/j.npep.2020.102019","volume":"80","author":"YP Pan","year":"2020","unstructured":"Pan YP, Liu C, Liu MF, Wang Y, Bian K, Xue Y, Chen L. Involvement of orexin-A in the regulation of neuronal activity and emotional behaviors in central amygdala in rats. Neuropeptides. 2020;80:102019. https:\/\/doi.org\/10.1016\/j.npep.2020.102019.","journal-title":"Neuropeptides"},{"key":"7727_CR25","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1097\/01.mco.0000078995.96795.91","volume":"6","author":"T Sakurai","year":"2003","unstructured":"Sakurai T. Orexin: a link between energy homeostasis and adaptive behaviour. Curr Opin Clin Nutr Metab Care. 2003;6:353\u201360. https:\/\/doi.org\/10.1097\/01.mco.0000078995.96795.91.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"7727_CR26","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1159\/000514960","volume":"45","author":"B Toor","year":"2021","unstructured":"Toor B, Ray LB, Pozzobon A, Fogel SM. Sleep, Orexin and Cognition. Front Neurol Neurosci. 2021;45:38\u201351. https:\/\/doi.org\/10.1159\/000514960.","journal-title":"Front Neurol Neurosci"},{"key":"7727_CR27","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.neuropharm.2018.09.034","volume":"154","author":"D Sargin","year":"2019","unstructured":"Sargin D. The role of the orexin system in stress response. Neuropharmacology. 2019;154:68\u201378. https:\/\/doi.org\/10.1016\/j.neuropharm.2018.09.034.","journal-title":"Neuropharmacology"},{"key":"7727_CR28","doi-asserted-by":"publisher","first-page":"172929","DOI":"10.1016\/j.pbb.2020.172929","volume":"194","author":"DF Berhe","year":"2020","unstructured":"Berhe DF, Gebre AK, Assefa BT. Orexins role in neurodegenerative diseases: from pathogenesis to treatment. Pharmacol Biochem Behav. 2020;194:172929. https:\/\/doi.org\/10.1016\/j.pbb.2020.172929.","journal-title":"Pharmacol Biochem Behav"},{"key":"7727_CR29","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.neures.2010.06.010","volume":"68","author":"E Kitamura","year":"2010","unstructured":"Kitamura E, Hamada J, Kanazawa N, Yonekura J, Masuda R, Sakai F, Mochizuki H. The effect of orexin-A on the pathological mechanism in the rat focal cerebral ischemia. Neurosci Res. 2010;68:154\u20137. https:\/\/doi.org\/10.1016\/j.neures.2010.06.010.","journal-title":"Neurosci Res"},{"key":"7727_CR30","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12974-019-1447-y","volume":"16","author":"L Becquet","year":"2019","unstructured":"Becquet L, Abad C, Leclercq M, Miel C, Jean L, Riou G, Couvineau A, Boyer O, Tan YV. Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation. J Neuroinflammation. 2019;16:64. https:\/\/doi.org\/10.1186\/s12974-019-1447-y.","journal-title":"J Neuroinflammation"},{"key":"7727_CR31","doi-asserted-by":"publisher","first-page":"e0182707","DOI":"10.1371\/journal.pone.0182707","volume":"12","author":"HR Modi","year":"2017","unstructured":"Modi HR, Wang Q, Gd S, Sherman D, Greenwald E, Savonenko AV, Geocadin RG, Thakor NV. Intranasal post-cardiac arrest treatment with orexin-A facilitates arousal from coma and ameliorates neuroinflammation. PLoS ONE. 2017;12:e0182707. https:\/\/doi.org\/10.1371\/journal.pone.0182707.","journal-title":"PLoS ONE"},{"key":"7727_CR32","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s12031-013-0165-7","volume":"52","author":"P Soko\u0142owska","year":"2014","unstructured":"Soko\u0142owska P, Urba\u0144ska A, Biega\u0144ska K, Wagner W, Ciszewski W, Namieci\u0144ska M, Zawilska JB. Orexins protect neuronal cell cultures against hypoxic stress: an involvement of Akt signaling. J Mol Neurosci. 2014;52:48\u201355. https:\/\/doi.org\/10.1007\/s12031-013-0165-7.","journal-title":"J Mol Neurosci"},{"key":"7727_CR33","doi-asserted-by":"publisher","first-page":"1045034","DOI":"10.3389\/fncel.2022.1045034","volume":"16","author":"D Zhang","year":"2022","unstructured":"Zhang D, Cui Y, Zhao M, Zheng X, Li C, Wei J, Wang K, Cui J. Orexin-A exerts neuroprotective effect in experimental intracerebral hemorrhage by suppressing autophagy via OXR1-mediated ERK\/mTOR signaling pathway. Front Cell Neurosci. 2022;16:1045034. https:\/\/doi.org\/10.3389\/fncel.2022.1045034.","journal-title":"Front Cell Neurosci"},{"key":"7727_CR34","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3892\/mmr.2021.11905","volume":"23","author":"D Xu","year":"2021","unstructured":"Xu D, Kong T, Cheng B, Zhang R, Yang C, Chen J, Wang C. Orexin-A alleviates cerebral ischemia-reperfusion injury by inhibiting endoplasmic reticulum stress-mediated apoptosis. Mol Med Rep. 2021;23:266. https:\/\/doi.org\/10.3892\/mmr.2021.11905.","journal-title":"Mol Med Rep"},{"key":"7727_CR35","doi-asserted-by":"publisher","first-page":"111105","DOI":"10.1016\/j.brainresbull.2024.111105","volume":"218","author":"M Zhu","year":"2024","unstructured":"Zhu M, Li X, Guo J, Zhang Z, Guo X, Li Z, Lin J, Li P, Jiang Z, Zhu Y. Orexin A protects against cerebral ischemia-reperfusion injury by enhancing reperfusion in ischemic cortex via HIF-1\u03b1-ET-1\/eNOS pathway. Brain Res Bull. 2024;218:111105. https:\/\/doi.org\/10.1016\/j.brainresbull.2024.111105.","journal-title":"Brain Res Bull"},{"key":"7727_CR36","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1007\/s10072-019-3708-z","volume":"40","author":"M Gencer","year":"2019","unstructured":"Gencer M, Akbay\u0131r E, \u015een M, Arsoy E, Y\u0131lmaz V, Bulut N, T\u00fcz\u00fcn E, T\u00fcrko\u011flu R. Serum orexin-A levels are associated with disease progression and motor impairment in multiple sclerosis. Neurol Sci. 2019;40:1067\u201370. https:\/\/doi.org\/10.1007\/s10072-019-3708-z.","journal-title":"Neurol Sci"},{"key":"7727_CR37","first-page":"4110","volume":"15","author":"J Li","year":"2023","unstructured":"Li J, Wang Q, Qian J, Chen X, Li D, Song C. Correlation of serum orexin-A level with cognitive function and serum inflammatory cytokines in epileptic patients. Am J Transl Res. 2023;15:4110\u20137. PMID:37434836.","journal-title":"Am J Transl Res"},{"key":"7727_CR38","doi-asserted-by":"publisher","first-page":"187","DOI":"10.5665\/sleep.1618","volume":"35","author":"A Aran","year":"2012","unstructured":"Aran A, Shors I, Lin L, Mignot E, Schimmel MS. CSF levels of hypocretin-1 (orexin-A) peak during early infancy in humans. Sleep. 2012;35:187\u201391. https:\/\/doi.org\/10.5665\/sleep.1618.","journal-title":"Sleep"},{"key":"7727_CR39","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/j.1447-0756.2012.01955.x","volume":"39","author":"E Yilmaz","year":"2013","unstructured":"Yilmaz E, Celik O, Celik N, Celik E, Turkcuoglu I, Simsek Y, Minareci Y, Boz M, Aydin S. Maternal and fetal serum orexin-A levels in gestational diabetes mellitus. J Obstet Gynaecol Res. 2013;39:139\u201345. https:\/\/doi.org\/10.1111\/j.1447-0756.2012.01955.x.","journal-title":"J Obstet Gynaecol Res"},{"key":"7727_CR40","doi-asserted-by":"publisher","first-page":"748150","DOI":"10.3389\/fneur.2021.748150","volume":"12","author":"R Chavez-Valdez","year":"2021","unstructured":"Chavez-Valdez R, Miller S, Spahic H, Vaidya D, Parkinson C, Dietrick B, Brooks S, Gerner GJ, Tekes A, Graham EM, Northington FJ, Everett AD. Therapeutic hypothermia modulates the relationships between indicators of severity of neonatal hypoxic ischemic encephalopathy and serum biomarkers. Front Neurol. 2021;12:748150. https:\/\/doi.org\/10.3389\/fneur.2021.748150.","journal-title":"Front Neurol"},{"key":"7727_CR41","doi-asserted-by":"publisher","first-page":"1288853","DOI":"10.3389\/fped.2024.1288853","volume":"12","author":"H Lv","year":"2024","unstructured":"Lv H, Wang Q, Liu F, Jin L, Ren P, Li L. A biochemical feedback signal for hypothermia treatment for neonatal hypoxic-ischemic encephalopathy: focusing on central nervous system proteins in biofluids. Front Pediatr. 2024;12:1288853. https:\/\/doi.org\/10.3389\/fped.2024.1288853.","journal-title":"Front Pediatr"},{"key":"7727_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41390-026-04924-6","author":"M O\u2019Dea","year":"2026","unstructured":"O\u2019Dea M, Hurley T, Branagan A, McCarthy R, Stewart P, Tamgumus S, Kyng KJ, Mockler D, Chalak L, Molloy EJ. Neonatal encephalopathy biomarkers: outcome prediction from blood samples: systematic review and meta-analysis. Pediatr Res. 2026. https:\/\/doi.org\/10.1038\/s41390-026-04924-6. Online ahead of print.","journal-title":"Pediatr Res"},{"key":"7727_CR43","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1097\/PCC.0000000000000155","volume":"15","author":"AN Massaro","year":"2014","unstructured":"Massaro AN, Chang T, Baumgart S, McCarter R, Nelson KB, Glass P. Biomarkers S100B and neuron-specific enolase predict outcome in hypothermia-treated encephalopathic newborns. Pediatr Crit Care Med. 2014;15:615\u201322. https:\/\/doi.org\/10.1097\/PCC.0000000000000155.","journal-title":"Pediatr Crit Care Med"},{"key":"7727_CR44","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1515\/cclm-2018-1094","volume":"57","author":"I Bersani","year":"2019","unstructured":"Bersani I, Ferrari F, Lugli L, Ivani G, Conio A, Moataza B, Aboulgar H, Mufeed H, Iskander I, Kornacka M, Gruzfeld D, Dotta A, Savarese I, Chukhlantseva N, Tina LG, Nigro F, Livolti G, Galvano F, Serpero L, Colivicchi M, Ianniello P, Pluchinotta F, Anastasia L, Baryshnikova E, Gazzolo D. Monitoring the effectiveness of hypothermia in perinatal asphyxia infants by urinary S100B levels. Clin Chem Lab Med. 2019;57:1017\u201325. https:\/\/doi.org\/10.1515\/cclm-2018-1094.","journal-title":"Clin Chem Lab Med"},{"key":"7727_CR45","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1515\/cclm-2022-0559","volume":"60","author":"I Bersani","year":"2022","unstructured":"Bersani I, Gasparroni G, Bashir M, Aboulgar H, Mufeed H, Iskander I, Kornacka M, Gruzfeld D, Dotta A, Campi F, Longo D, Savarese I, Braguglia A, Tina LG, Nigro F, Serpero L, Strozzi MC, Maconi A, Ianniello P, Di Battista C, D\u2019Adamo E, Gavilanes D, Gazzolo D. Early predictors of abnormal MRI patterns in asphyxiated infants: S100B protein urine levels. Clin Chem Lab Med. 2022;60:1745\u201352. https:\/\/doi.org\/10.1515\/cclm-2022-0559.","journal-title":"Clin Chem Lab Med"},{"key":"7727_CR46","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/j.1651-2227.2011.02480.x","volume":"101","author":"A Roka","year":"2012","unstructured":"Roka A, Kelen D, Halasz J, Beko G, Azzopardi D, Szabo M. Serum S100B and neuron-specific enolase levels in normothermic and hypothermic infants after perinatal asphyxia. Acta Paediatr. 2012;101:319\u201323. https:\/\/doi.org\/10.1111\/j.1651-2227.2011.02480.x.","journal-title":"Acta Paediatr"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-026-07727-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-026-07727-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-026-07727-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T10:46:42Z","timestamp":1791456402000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12887-026-07727-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,21]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7727"],"URL":"https:\/\/doi.org\/10.1186\/s12887-026-07727-0","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,21]]},"assertion":[{"value":"19 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki, and the study protocol was approved by the Institutional Ethics Committee of the University of Health Sciences, Izmir Tepecik Training and Research Hospital (Decision number:1\u201307\/12\/2020). A written informed consent was obtained from newborns\u2019 parents or legal guardian following a detailed explanation of the objectives and protocol.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"968"}}